Advances in In Vivo Quantitative and Qualitative Imaging Characterization of Gliomas
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 30 June 2024 | Viewed by 2737
Special Issue Editors
Interests: nuclear medicine; oncology; PET imaging; brain tumor
Special Issues, Collections and Topics in MDPI journals
Interests: cerebral aneurysms; brain tumors; moyamoya; neuro-oncology; neuroprotection; peripheral nerves; subarachnoid hemorrhage
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Gliomas are the most common intra-axial primary tumors of the central nervous system arising from glial cells.
The current standard of care imaging on brain tumors relies heavily on conventional MRI. More advanced MR techniques, including perfusion and diffusion-weighted imaging, and spectroscopy, are increasingly utilized in clinical and research capacities to help predict tumor types.
PET imaging is an accurate tool for detecting areas of dedifferentiation in diffuse gliomas, differentiating pseudo-progression from real tumor progression, and in the follow-up of high-grade gliomas.
Other imaging modalities are under development for more accurate characterization of brain tumors during the surgery (intraoperative ultrasound) and to improve the structural evaluation of brain tumors (Optical coherence tomography).
In-Vivo quantification of morpho-functional imaging could be crucial for improving the diagnostic work-up and management of gliomas.
This Special Issue will focus on developing In-Vivo Quantitative and Qualitative Imaging (CT, OCT, MRI, PET/CT, PET/MR), also considering the novel application of Radiomics to improve the current role of imaging in the management of Gliomas.
We invite authors to submit contributions that provide novel findings or reviews that comprehensively highlight the latest discoveries in the field.
Dr. Pierpaolo Alongi
Dr. Ignazio Gaspare Vetrano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PET
- PET/CT
- PET/MR
- MR
- CT
- OCT
- US
- gliomas
- artificial intelligence
- radiomics
- in-vivo quantitative imaging
